Cost-effectiveness analysis of paclitaxel and cisplatin versus cyclophosphamide and cisplatin as first-line therapy in advanced ovarian cancer. A European perspective

By Berger K.   Fischer T.   Szucs T.D.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1894-1901

Elsevier

Access to resources Recommend Favorite

Dose-dense cisplatin/paclitaxel - a well-tolerated and highly effective chemotherapeutic regimen in patients with advanced ovarian cancer

By de Jongh F.E.   de Wit R.   Verweij J.   Sparreboom A.   van den Bent M.J.   Stoter G.   van der Burg M.E.L.  

European Journal of Cancer, Vol. 38, Iss. 15, 2002-10 ,pp. : 2005-2013

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Triplet Combination Chemotherapy of Paclitaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer

By Kimura Yutaka   Yano Hiroshi   Imamura Hiroshi   Fujitani Kazumasa   Imano Motohiro   Tokunaga Yukihiko   Matsuoka Masaki   Kurokawa Yukinori   Shimokawa Toshio   Takiuchi Hiroya   Tsujinaka Toshimasa   Furukawa Hiroshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 125-131

Oxford University Press

Access to resources Recommend Favorite

Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

By Kim Jong   Sohn Sang   Song Hong   Kwon Ki-Young   Do Young   Lee Kyung   Hyun Myung   Ryoo Hun   Bae Sung   Park Keon   Baek Jin   Lee Won   Chung Joo   Cho Goon   Sohn Chang-Hak   Jang Jung   Chung Ho   Yu Wansik  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 6, 2007-11 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

Paclitaxel and Cisplatin Combination Chemotherapy in Recurrent Epithelial Ovarian Cancer

By Goldberg J.M.   Piver M.S.   Hempling R.E.   Recio F.O.  

Gynecologic Oncology, Vol. 63, Iss. 3, 1996-12 ,pp. : 312-317

Academic Press

Access to resources Recommend Favorite